Company news
Episurf Medical Ab Class B (OMXSTO:EPIS_B) news
Episurf Medical Ab Class B news releases on 6ix. Latest, Jun 26, 2026: Episurf Medical Enters Into Financing Deal For Klarabo Acquisition
Press releases & updates
Episurf Medical Enters Into Financing Deal For Klarabo Acquisition
June 26, 2026
Mofast Reaches 28% Ownership In Episurf
June 10, 2026
Episurf Medical Acquires Property Portfolio
June 5, 2026
Episurf Medical Acquires Portfolio Of Four Properties
May 29, 2026
Frusipe Intressenter Holding Divests Shares In Episurf Medical
May 27, 2026
Episurf Medical Acquires Properties In Borås
May 26, 2026
EPIS_B: Transformation to a property-focused company drove strong sales growth but higher losses
May 25, 2026
Episurf Medical Acquires Real Estate Portfolio From Lilium
May 22, 2026
Episurf Medical Appoints Christian Olofsson As Deputy CEO
May 21, 2026
Episurf Medical Buys Property Portfolio
May 11, 2026
Episurf Medical Signs LoI To Acquire Real Estate Portfolios
May 5, 2026
Lars Lönnquist Proposed As Chairman Of Board Of Episurf Medical Until Next AGM
April 21, 2026
Episurf Medical To Pursue Separation Of Medtech Operations
April 20, 2026
Episurf Medical Acquires Property Portfolio With Agreed Property Value Of SEK 697 Mln
April 2, 2026
Episurf Medical: New U.S. Patent Approval
February 25, 2026
Episurf Medical To Issue Class B Shares, Debentures
February 24, 2026
Jens Andersson Appointed As CEO Of Episurf
February 10, 2026
EPIS_B: Operating losses narrowed as sales grew and real estate investments began, but financing risks remain
February 6, 2026
Episurf Acquires Properties From Klarabo
January 26, 2026
Episurf Acquires Real Estate Assets, Forms New Business Segment
December 30, 2025
Episurf's Implants Market Approved In Singapore
November 4, 2025
EPIS_B: US growth and cost savings drive improved results, but financing uncertainty persists
October 24, 2025
Episurf Medical AB: Quarterly Trading Report 2025 Q3
October 3, 2025
EPIS_B: Adjusted EBIT improved, U.S. order intake surged, and a SEK 29.4m rights issue is planned
July 11, 2025
EPIS_B: Record Q1 sales and US growth position Episurf for accelerated expansion and improved results
April 10, 2025
EPIS_B: Net sales grew, losses narrowed, and US market expansion accelerated, supported by new funding
February 5, 2025
EPIS_B: Q3 saw improved results, US expansion, and strong order growth; 510(k) clearance expected 2025
October 25, 2024
EPIS_B: Strong sales growth and improved losses as US expansion and cost savings accelerate
July 12, 2024